Table 2. Multivariable adjusted associations of sleep measures with inflammatory burden as the dependent variable.
| βϯ | SE | p | |
|---|---|---|---|
|
|
|||
| AHI ≥30 vs. <30 | 0.11 | 0.07 | 0.088 |
| ≥10% vs. <10% TST SaO2<90% | 0.24 | 0.08 | 0.002 |
| ≥1% vs. <1% TST SaO2<80% | -0.14 | 0.13 | 0.27 |
| TST <5 vs. 5-8 | 0.20 | 0.08 | 0.013 |
| TST >8 vs. 5-8 | 0.00 | 0.10 | 0.99 |
| Sleep latency ≥60 vs. <60 min | 0.12 | 0.08 | 0.14 |
| WASO ≥90 vs. <90 min | 0.13 | 0.05 | 0.024 |
β coefficient (after MV adjustments) from linear regression; similar results observed using negative binomial regression
MV=Multivariable models adjusted for: age, study site, race, BMI, probable depression, cognition, smoking status, alcohol use, education, caffeine use, physical activity, chronic disease (any arthritis (including osteoarthritis or rheumatoid arthritis), cardiovascular disease (CVD), stroke, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and hypertension), self-reported health and medication use (antidepressants, benzodiazepines, sedatives/hypnotics, NSAIDs, and corticosteroids)